Rising Prevalence of Chronic Diseases Boost Demand for Wearable Injectors

The wearable injectors industry contributes $6.95 billion in 2021, and it is projected to advance at a rate of 12.6% from 2021 to 2030, to generate $20.21 billion in 2030. It is ascribed to rising health hazard concerns, led by conventional injectors, coupled with growing demand for conventional and novel drug molecules.

In addition, the rising prevalence of chronic diseases, including cancer, diabetes, and cardiovascular diseases, and favorable reimbursement policies are projected to boost the demand for wearable injectors in the coming years.

Infusion therapy costs around $35 billion in the specialty drug industry. The subcutaneous injection is the most popular administration route in various therapeutic areas, including hemophilia, cancer, autoimmune disorders, and multiple sclerosis. It accounts for 50% of the expenditure on specialty medicine in the U.S.

Furthermore, biological drugs are large molecules, and more viscous compared to other drugs. They cause lesser pain during injection. The usage of the biological molecules with pharmacokinetics and subcutaneous back pressure boosts the usage of the biological molecules.

The slow administration of the drug is required for reducing patient discomfort and improving the drug's performance. For example, immunoglobulins are used for administering large volumes, and therefore, the preferred method is subcutaneous delivery. Immunoglobulins are administered in a specialized clinic or in a hospital through insertion sets or syringe pumps.

The major players operating in the industry are; Medtronic plc, SteadyMed Ltd., Ypsomed Group, Unilife Corporation, Insulet Corporation, F.Hoffmann-La Roche Ltd., Johnson & Johnson, Becton, Dickinson, and Company, and West Pharmaceutical Services Inc.

Therefore, the rising demand for wearable injectors is led by the growing prevalence of chronic diseases.

Read More

Incidence of Alzheimer Spur Nerve Repair and Regeneration Demand

 Due to the intricate and fragile components, the nervous system, which consists of the spinal cord, brain, and peripheral nerves, is vulnerable to several kinds of harm. The market for nerve healing biomaterials is expanding because of the rising frequency of nerve damage.

The demand for nerve repair and regeneration is predicted to touch $17.47 billion by 2030. This can be attributed mostly to the increase in traumatic brain injuries (TBIs) and other neurological conditions such as ataxia, acute spinal cord injury, and Alzheimer's disease.

Devices for neuromodulation, neurostimulation, and biomaterials make up the products for nerve repair and regeneration. These cutting-edge tools and materials are used to treat everything from injuries to neurodegenerative illnesses including Alzheimer's disease, Parkinson's disease, multiple sclerosis, multiple system atrophy, and others.  

Additionally, developing nations like Brazil, China, and India are providing attractive expansion chances for the domain. This is due to these nations' high populations, rising rates of neurological disorders, and rising healthcare costs. 

It is also anticipated that the count of stem cell treatments currently undergoing clinical trials will increase, as will the number of therapies that have previously received approval and been put into use.

Furthermore, bioengineering techniques for restoring vision have started a new age in the medical field. For the therapy of diabetic peripheral neuropathy, Medtronic has introduced Intellis and Vanta neurostimulators.

Numerous people with crippling neurological and psychological diseases are finding relief because of the quick developments in neurostimulation technology. Both non-invasive and invasive techniques that employ electrical stimulation to create a neuronal function within a circuit are included in neurostimulation therapy.

Pediatric patients have benefited greatly from recent breakthroughs including the functional examination and characterization of adipose tissue via surgical correction using bone grafts.

Additionally, new developments in the healthcare industry have been sparked by bioengineering techniques for recovering eyesight. Thus, the demand for nerve regeneration and repair might experience significant growth.

Read More

Rising Environmental Concerns Boost the Demand for Biomass Pellets

The biomass pellet industry has garnered $9.05 billion revenue in 2021, and it is predicted to rise at the rate of 6.75% from 2021 to 2030, to generate $16.29 billion revenue in 2030. The rising awareness of the benefits of utilizing biofuels and other renewable energy sources for commercial, residential, and industrial heating and power generation applications propels industry growth.

In addition, the government initiatives to encourage the adoption of renewable energy sources, growing low-carbon fuel demand, and availability of raw materials are several factors to fuel the biomass pellets demand.

Under the source segment, wood sawdust dominates the industry, accounting for a 50% share in 2021, and it is projected to rise at a higher rate in the coming years. 

Wood sawdust is burnt to produce steam, that can be utilized in generating power and supplying heat to commercial and residential spaces. That is why it is predicted to propel the wood sawdust-based pellets industry in the coming future.

The rising demand for renewable energy sources such as biomass pellets is led by the depletion of fossil fuel resources, and surging awareness of harmful environmental effects caused by the usage of fossil fuel-based products and processes.

In addition, the surging requirement for sustainable energy development is projected to fuel the requirement for biomass pellets.

Renewable energy sources and technologies cause little or no impact on the environment, compare to other energy sources. That is why they are considered environmentally friendly.

Europe leads the biomass pellet industry, accounting for a 30% share in the industry, and the region-based is projected to rise at the fastest rate. It is ascribed to the rising demand for biomass pellets in power generation, including favorable government policies to aid energy renewable sources. 

The major players operating in the industry are; AS Graanul Invest, Buhler AG, Lignetics, The Westervelt Company Inc., Forest Energy Corporation, New England Wood Pellet, and German Pellets Gmbh.

Therefore, the rising environmental concerns boost the demand for biomass pellets.

Read More

APAC had Largest Share of 38% in Solar Control Films Industry

The size of the solar control films market was over $728 million in 2021, which will reach about $1,284 million by 2030, growing at a rate of around 7% in the near future. 

This is because of the rising consciousness of the compensations of solar control films as compared to sun-reflective glass, snowballing rate of real- estate development, and surging emphasis on lessening of energy costs and carbon footprint.

Vacuum variants had the largest share of revenue, of over 40%, in the recent past, and they will grow at a significant rate in the near future. This development has a lot to do with the rise in the construction and advance in the use in automobiles, as these films reflect the solar radiation and keep the interiors much cooler than other films.

Construction sector dominated the industry of solar control films with over 52%, in the recent past, because of the growing use of these materials in residential and commercial buildings. The rapid infra growth in China, Brazil, Malaysia, India and South Africa, has affected the requirement for solar control films.

The solar control films market of the APAC had a share of over 38% in the past, and it will grow significantly in the future. This is chiefly credited to the increasing investment on construction and warm weather all over the year in most of the region. Additionally, the region is the fastest-growing, because of the presence of India and China.

North America follows the APAC region because of the budding automotive industry. Moreover, the construction industry in the region is booming because of the advantageous policies for lenders and the economic recovery, which have led to a resurgence in the requirement for residential vicinities.

It is because of the growing construction industries and increasing environmental concerns, the demand for solar control films is on the rise around the world.

Read More

High Demand for Anti-VEGF Therapeutics for Ophthalmic Treatment

The advent of anti-vascular endothelial growth has massively resulted in reducing the vision loss caused by neovascular age-related macular degeneration (n-AMD). 

The response of the anti-VEGF therapy relies on various factors such as the patient’s lesion characteristics, age, lesion duration, baseline visual acuity, and various genotype risk alleles. 

In addition, individuals affected with n-AMD result in decreasing morphology or acuity, even after therapy, or it may need frequent re-treatment. 

Vascular endothelial growth factor involves numerous pathological processes. It is widely utilized in the R&D of various illness therapies. 

The anti-VEGF therapeutics industry has generated $12,178.0 million revenue in 2021, and it is projected to generate $13,812.6 million revenue, advancing at a rate of 1.4% from 2021 to 2030. It is widely influenced by FDA approvals for products in the pipeline, including R&D activities in the field.

VEGF results in the development of diabetic retinopathy, and age-related macular degeneration in wet form. Therefore, anti-VEGF is crucial for the treatment of such conditions.

Moreover, the rising prevalence of ophthalmic diseases such as AMD, macular edoema, DR, and retinal vein occlusion, due to the increasing elderly population propels the risk of developing various diseases. It leads to increased demand for anti-VEGF therapeutics to treat such conditions.

On average, people aged 50 years or more are more likely to get blind due to rising incidences of AMD. More than 6.22 million people are more likely to be affected by moderate-to-sever vision impairment. Furthermore, the rising adoption of anti-VEGF medications has resulted in reduced incidences of AMD blindness by 20% from 2000 to 2020.

Read More

Life Sciences Analytics: Why It Has Tremendous Potential

Before we understand the analytical part, we must know what are life sciences. In the language, understood by the layman, life sciences means the study of living organisms and understanding of the life processes. This study is an ongoing process and advancements in medical studies are the results of these studies. The life science analytics industry will reach $18,386 million by 2030. 

Now, let’s come to the analytical part of life sciences. An important thing for the continuous growth in the medical advancement is research. And, this research is possible only if the right kind of applications are used to collect and analyze the data. These analytical applications used in the clinical research, pharmaceutical research, and several other medical research divisions to analyze life studies are called Life Sciences Analytics.

Life sciences includes study of genetics, molecular biology, microbiology, zoology, evolution, ecology, physiology, and botany. 

Who does All the Research?

The Life Sciences industry includes various companies working around research, data analysis and development of humans, animals and plants. The Pharmaceuticals industry, healthcare industry, and biotech industry are often considered Life Science industries, since their focus is mainly on improving the health and longevity of life.

With increasing volume of patient data, the demand for life sciences analytics tools or applications have also increased. These tools are analytics software are application based or close-based. Larger pharmaceutical, healthcare, and medical device enterprises have the larger client base for these kinds of solution providers.

Life science focus more on business intelligence solutions. Hence, these holistic tools that navigate healthcare reforms and optimize supply chains are in huge demand.

Why Companies Need these Solutions 

These Life sciences solutions decrease the cost of running businesses, reduces the chances of corruption of data due to human interference, and improve the engagement between healthcare organizations and customers.

Pharmaceutical and Biotechnology are the major clients of life sciences analytics solutions. Pharma industry require these solutions for drug development, improving patient outcomes. Biotechnology firms need these to have more efficient industrial manufacturing processes.

Life sciences analytics tools help industry in product expansion, modulating research and development and analytics supports in regulatory compliance. 

The analytics plays an important role in the life sciences mainly by detecting the treatment and prescription patterns, planning the outcome of the same on the patient in real-life and also by achieving operational brilliance. 

Analytical science plays a vital role in guaranteeing public safety and security. For instance, these pieces of equipment are used at airports to find drugs and dangerous materials, such as explosives. Such piece of equipment is designed in way that they can detect any unwanted substance accurately even if a small amount of these substances is present with the people, who are ready to board the flights

The growing need for life science analytics from Pharmaceutical and Biotechnology will drive the demand for life Science analytics solutions all over the world.

Read More

North America Leading the Enteral Nutrition Market

 The size of the enteral nutrition market size was $8,038 million in 2021, and will reach $13,812 million by 2030, at a rate of over 6% in the years to come. This growth can be credited to the growing elderly population, increasing count of victims of undernourishment getting treated, and lower product cost.

The standard enteral nutrition dominated the industry in the past. This is mainly because of the extensive acceptance of regular protein diets, as it is one of the preferred compositions recommended for patients with diabetes, cancer, and other ailments making it difficult to consume solid meals. The initiation of protein-rich products is meeting the demand.

Protein nutrients held a larger share in the past, because of the snowballing consumer consciousness regarding balanced diets all over the globe. The augmented requirement for protein nutrients is pushed by socio-economic alterations like rising usable income, the elderly population, and the acknowledgement of the role of protein in a balanced and healthy diet.

The hospital pharmacies had the largest revenue share of share, of over 60%, in the past, and will continue like this in the future also. This is because of the growing volume of inpatients and outpatients in hospitals, along with preference of patients for hospital pharmacies.

Online pharmacies will experience the highest growth in the future. The main reason for this can be the improved patient-provider communication, and promotional campaigns will surge the online delivery of enteral feeding products for critical patients. Similarly, it provides ease to patients with the essentials delivered at their doorstep.

Adult patients will be the largest end-users in the near future. Also, patients who have a body mass index of <20 are regarded as chronically ill and suffer from gastrointestinal diseases, respiratory issues, cancer, and neurological or psychiatric ailments. These patients are at higher risk for undernourishment, and such factor inspires the industrial growth.

North America dominated the regional enteral nutrition market with over 33% in the past. This is because of the well-recognized healthcare sector and the existence of numerous product manufacturers. Furthermore, the increased usage of nutritional products and the increase in the patient volume suffering from chronic diseases have enhanced the requirement for nutrition products.

The absorption capacity of the human digestive system reduces with growing age, making it hard for the body to retain all of the essential nutrients from food. Appetite loss is a main issue with the elderly. Consequently, elderly do not receive adequate vitamins. Therefore, the elderly people are more reliant on nutrition supplements for keeping active, which increases the demand for enteral nutrition.

 The increasing number of people suffering from chronic diseases, and the ever-increasing elderly population in the world propels the demand for enteral nutrition.

Read More